Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caduet versus usual care for multifactorial cardiovascular risk management in hypertension
2006-004794-10Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amlodipine and atorvastatin in hypertension (HTN) (2 arms), sponsored by Pfizer. Primary endpoint: Month 12 Framingham 10-year risk. Started Jan 2007; status: completed.
02
Drugs
amlodipineatorvastatin
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2006-004794-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004794-10.